Overall, these data indicate that the HBc VLP vaccine itself had no effects on tumor growth inhibition, but could effectively control tumor growth and significantly improve the survival of treated mice in combination with FOSCAN-PDT. The gene discussed is KRT88P; the disease is neoplasm.